Quarterly report · Q1
4465.TEDINET S100RZY6
Period2023-06-01 → 2023-08-31
Filed2023-10-12
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 31
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥5.5bn | 2023-06-01 → 2023-08-31 | Cons. | Net sales |
| Revenue | ¥19.5bn | 2022-06-01 → 2023-05-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥4.7bn | 2022-06-01 → 2022-08-31 | Cons. | Net sales |
| Operating income | ¥288m | 2023-06-01 → 2023-08-31 | Cons. | Operating income |
| Operating income | ¥357m | 2022-06-01 → 2022-08-31 | Cons. | Operating income |
| Ordinary income | ¥302m | 2023-06-01 → 2023-08-31 | Cons. | Ordinary income |
| Ordinary income | ¥887m | 2022-06-01 → 2023-05-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥367m | 2022-06-01 → 2022-08-31 | Cons. | Ordinary income |
| Profit before tax | ¥300m | 2023-06-01 → 2023-08-31 | Cons. | Income before income taxes |
| Profit before tax | ¥367m | 2022-06-01 → 2022-08-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥198m | 2023-06-01 → 2023-08-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥562m | 2022-06-01 → 2023-05-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥234m | 2022-06-01 → 2022-08-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥200m | 2023-06-01 → 2023-08-31 | Cons. | Profit loss |
| Net income | ¥234m | 2022-06-01 → 2022-08-31 | Cons. | Profit loss |
| Total assets | ¥23.3bn | at 2023-08-31 | Cons. | Assets |
| Total assets | ¥23.6bn | at 2023-05-31 | Cons. | Assets |
| Total assets | ¥21.1bn | at 2022-08-31 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥10.2bn | at 2023-08-31 | Cons. | Liabilities |
| Total liabilities | ¥10.6bn | at 2023-05-31 | Cons. | Liabilities |
| Net assets / equity | ¥13.1bn | at 2023-08-31 | Cons. | Net assets |
| Net assets / equity | ¥13.0bn | at 2023-05-31 | Cons. | Net assets |
| Net assets / equity | ¥12.8bn | at 2022-08-31 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥6.8bn | at 2023-08-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥6.7bn | at 2023-05-31 | Cons. | Cash and deposits |
| EPS (basic) | ¥33.49 | 2023-06-01 → 2023-08-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥95.13 | 2022-06-01 → 2023-05-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥39.68 | 2022-06-01 → 2022-08-31 | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 55.7% | at 2023-08-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 54.6% | at 2023-05-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 60.4% | at 2022-08-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 15
| Segment | Item | Period | Value |
|---|---|---|---|
| jpcrp040300-q1r_E00890-000Chemical Businessreportable segment | revenue | 2023-06-01 → 2023-08-31 | ¥5.1bn |
| jpcrp040300-q1r_E00890-000Chemical Businessreportable segment | revenue external | 2023-06-01 → 2023-08-31 | ¥5.1bn |
| jpcrp040300-q1r_E00890-000Chemical Businessreportable segment | segment profit | 2023-06-01 → 2023-08-31 | ¥264m |
| jpcrp040300-q1r_E00890-000Healthcare Businessreportable segment | revenue | 2023-06-01 → 2023-08-31 | ¥374m |
| jpcrp040300-q1r_E00890-000Healthcare Businessreportable segment | revenue external | 2023-06-01 → 2023-08-31 | ¥374m |
| jpcrp040300-q1r_E00890-000Healthcare Businessreportable segment | segment profit | 2023-06-01 → 2023-08-31 | ¥25m |
| —segment total | revenue | 2023-06-01 → 2023-08-31 | ¥5.5bn |
| —segment total | revenue external | 2023-06-01 → 2023-08-31 | ¥5.5bn |
| —segment total | segment profit | 2023-06-01 → 2023-08-31 | ¥288m |
| jpcrp040300-q1r_E00890-000Chemical Businessreportable segment | revenue | 2022-06-01 → 2022-08-31 | ¥4.7bn |
| jpcrp040300-q1r_E00890-000Chemical Businessreportable segment | revenue external | 2022-06-01 → 2022-08-31 | ¥4.7bn |
| jpcrp040300-q1r_E00890-000Chemical Businessreportable segment | segment profit | 2022-06-01 → 2022-08-31 | ¥357m |
| —segment total | revenue | 2022-06-01 → 2022-08-31 | ¥4.7bn |
| —segment total | revenue external | 2022-06-01 → 2022-08-31 | ¥4.7bn |
| —segment total | segment profit | 2022-06-01 → 2022-08-31 | ¥357m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 334
| Item | Context | Value | Unit |
|---|---|---|---|
| Comprehensive income | Prior1YTDDuration | 328640000 | JPY |
| Comprehensive income | CurrentYTDDuration | 276834000 | JPY |
| Comprehensive income attributable to owners of the parent | Prior1YTDDuration | 328640000 | JPY |
| Comprehensive income attributable to owners of the parent | CurrentYTDDuration | 274705000 | JPY |
| Comprehensive income attributable to non controlling interests | Prior1YTDDuration | － | JPY |
| Comprehensive income attributable to non controlling interests | CurrentYTDDuration | 2128000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q1r_E00890-000ChemicalBusinessReportableSegmentsMember | 4652940000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q1r_E00890-000HealthcareBusinessReportableSegmentsMember | － | JPY |
| Revenues from external customers | Prior1YTDDuration_ReportableSegmentsMember | 4652940000 | JPY |
| Revenues from external customers | Prior1YTDDuration_ReconcilingItemsMember | － | JPY |
| Revenues from external customers | Prior1YTDDuration | 4652940000 | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q1r_E00890-000ChemicalBusinessReportableSegmentsMember | － | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q1r_E00890-000HealthcareBusinessReportableSegmentsMember | － | JPY |
| Transactions with other segments | Prior1YTDDuration_ReportableSegmentsMember | － | JPY |
| Transactions with other segments | Prior1YTDDuration_ReconcilingItemsMember | － | JPY |
| Transactions with other segments | Prior1YTDDuration | － | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q1r_E00890-000ChemicalBusinessReportableSegmentsMember | 4652940000 | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q1r_E00890-000HealthcareBusinessReportableSegmentsMember | － | JPY |
| Net sales | Prior1YTDDuration_ReportableSegmentsMember | 4652940000 | JPY |
| Net sales | Prior1YTDDuration_ReconcilingItemsMember | － | JPY |
| Net sales | Prior1YTDDuration | 4652940000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q1r_E00890-000ChemicalBusinessReportableSegmentsMember | 357041000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q1r_E00890-000HealthcareBusinessReportableSegmentsMember | － | JPY |
| Operating income | Prior1YTDDuration_ReportableSegmentsMember | 357041000 | JPY |
| Operating income | Prior1YTDDuration_ReconcilingItemsMember | － | JPY |
| Operating income | Prior1YTDDuration | 357041000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q1r_E00890-000ChemicalBusinessReportableSegmentsMember | 5132901000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q1r_E00890-000HealthcareBusinessReportableSegmentsMember | 374046000 | JPY |
| Revenues from external customers | CurrentYTDDuration_ReportableSegmentsMember | 5506948000 | JPY |
| Revenues from external customers | CurrentYTDDuration_ReconcilingItemsMember | － | JPY |
| Revenues from external customers | CurrentYTDDuration | 5506948000 | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q1r_E00890-000ChemicalBusinessReportableSegmentsMember | － | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q1r_E00890-000HealthcareBusinessReportableSegmentsMember | － | JPY |
| Transactions with other segments | CurrentYTDDuration_ReportableSegmentsMember | － | JPY |
| Transactions with other segments | CurrentYTDDuration_ReconcilingItemsMember | － | JPY |
| Transactions with other segments | CurrentYTDDuration | － | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q1r_E00890-000ChemicalBusinessReportableSegmentsMember | 5132901000 | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q1r_E00890-000HealthcareBusinessReportableSegmentsMember | 374046000 | JPY |
| Net sales | CurrentYTDDuration_ReportableSegmentsMember | 5506948000 | JPY |
| Net sales | CurrentYTDDuration_ReconcilingItemsMember | － | JPY |
| Net sales | CurrentYTDDuration | 5506948000 | JPY |
| Operating income | CurrentYTDDuration_jpcrp040300-q1r_E00890-000ChemicalBusinessReportableSegmentsMember | 263592000 | JPY |
| Operating income | CurrentYTDDuration_jpcrp040300-q1r_E00890-000HealthcareBusinessReportableSegmentsMember | 24726000 | JPY |
| Operating income | CurrentYTDDuration_ReportableSegmentsMember | 288319000 | JPY |
| Operating income | CurrentYTDDuration_ReconcilingItemsMember | － | JPY |
| Operating income | CurrentYTDDuration | 288319000 | JPY |
| Document title cover page | FilingDateInstant | Original text (Japanese)四半期報告書 | |
| Clause of stipulation cover page | FilingDateInstant | Original text (Japanese)金融商品取引法第24条の４の７第１項 | |
| Place of filing cover page | FilingDateInstant | Original text (Japanese)近畿財務局長 | |
| Filing date cover page | FilingDateInstant | 2023-10-12 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |